Carlsmed, Inc. CARL
14.40 USD -0.62 (-4.13%)
At closeNov 3, 2026, 6:17 PM EST
14.50 +0.10 +0.69%
After hours · Nov 3, 6:17 PM ET
14.27 Day range 15.26
8.50 52-week range 17.23
- YTD
- +16.60%
- 1 year
- +17.84%
Financial health
Altman Z-Score
6.48 Safe zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
4 / 9 Average
Nine pass/fail tests of profitability, leverage and efficiency.
FMP rating
C-1 / 5 overall
- DCF 1
- Return on Equity 1
- Return on Assets 1
- Debt / Equity 2
- P/E 1
- P/B 2
Valuation
P/E -5.8×
FY 2023 5y median -5.8× FY 2025
P/S 3.5×
FY 2023 5y median 4.7× FY 2025
P/B 1.8×
FY 2023 5y median -1.4× FY 2025
P/FCF -5.9×
FY 2023 5y median -5.9× FY 2025
EV/EBITDA -3.8×
FY 2023 5y median -3.8× FY 2025
EV/Sales 2.1×
FY 2023 5y median 5.0× FY 2025
FCF Yield -16.9%
FY 2023 5y median -16.9% FY 2025
Profitability
Gross Margin 75.3%
FY 2023 5y median 73.8% FY 2025
Operating Margin -60.5%
FY 2023 5y median -88.8% FY 2025
Net Margin -58.7%
FY 2023 5y median -89.3% FY 2025
ROE -30.0%
FY 2023 5y median 34.3% FY 2025
ROIC -26.2%
FY 2023 5y median -55.5% FY 2025
ROA -22.8%
FY 2023 5y median -46.8% FY 2025
Growth (YoY)
Revenue 85.9%
FY 2023 FY 2025
Operating Income -26.7%
FY 2023 FY 2025
EPS (diluted) -41.3%
FY 2023 FY 2025
Free Cash Flow -15.5%
FY 2023 FY 2025
Financial Health
Current Ratio 8.9×
FY 2023 5y median 5.6× FY 2025
Quick Ratio 8.7×
FY 2023 5y median 5.5× FY 2025
Debt / Equity 0.2×
FY 2023 5y median -0.2× FY 2025
Net Debt / EBITDA 2.4×
FY 2023 5y median 1.0× FY 2025
Interest Coverage -21.4×
FY 2023 5y median -21.4× FY 2025
Dividends
Dividend Yield 0.0%
FY 2023 5y median 0.0% FY 2025
Payout Ratio 0.0%
FY 2023 5y median 0.0% FY 2025
Annual · latest fiscal year ends 2025-12-31